Article Information
PubMed
Published By
History
- Received January 27, 2012
- Revision received March 26, 2012
- Accepted April 4, 2012
- First published May 16, 2012.
- Version of record published May 16, 2012.
Copyright & Usage
Copyright © 2012 the authors 0270-6474/12/327091-11$15.00/0
Author Information
Author contributions
Author contributions: I.A.K., S.K., D.A.S., and V.S.S. designed research; I.A.K., S.K., J.P., and C.H.-R. performed research; I.A.K., S.K., and J.P. analyzed data; I.A.K., S.K., D.A.S., and V.S.S. wrote the paper.
Disclosures
- Received January 27, 2012.
- Revision received March 26, 2012.
- Accepted April 4, 2012.
This work was supported by National Institute of Drug Abuse Grant DA011471 (D.A.S.) and National Cancer Institute Grant CA138684 (V.S.S.). We are grateful to P. Villalta and B. Mater at the University of Minnesota Cancer Center for assistance in the quantification of endocannabinoids and to L. G. Coicou, P. Cortez, C. E. McShane, M. Tracy, and D. Vetter for technical assistance.
The authors declare no competing financial interests.
- Correspondence should be addressed to Virginia S. Seybold, Department of Neuroscience, 6-145 Jackson Hall, 321 Church Street Southeast, Minneapolis, MN 55455. vseybold{at}umn.edu
Online Impact